Fresenius Medical Care



Similar documents
Q(K SVJM~jPagelIof 3

Ultimate Concepts Inc.

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

February 5, Dear Kristin Pabst,

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

DEC V,(9/azO (c 0 j

0 EC V-,) 133 Lj9a

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

(k)Suminary k

(k) SUMMARY DEC

AW Server 510 (k) Summary of Safety and Effectiveness

L~l t l V~! MAY ?

FEB Mr. Gordon J. Peters Director Regulatory Compliance DocuSys, Incorporated 820 S. University Boulevard, Suite 3-H Mobile, Alabama 36609

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

BMR ~131o-lvleccai Kesearcn Ltd.

GE Healthcare MAR

510(K) SUMMARY. 510(k) Number KOS'00-r

May 5, Dear Mr. Courtney:

July 24, Dear Ms. Rhodes:

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

January 12, Dear Amy Yang:

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

April 3, Dear Autumn Liu,

March 3, Dear Ms. Alice Gong,

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

March 20, Dear Mr. Chen:

University of Texas Medical School at Houston. April 14, 2015

510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

510(k) Summary. Dentsply Implants. April 30, 2013

51O(K) SUMMARY: Therapy family of devices.

510(k) SUMMARY. OPTION-vyM Urinary Catheter

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

JN (k) Summary Device Identification: Device Description:

I~r it NOV SIE T AENCORE Tongue Suspension System OCE L_ August 3, (k) Summary. Appendix 3:

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

Manufacturing Technology, Inc.

510(k) SUMMARY APR Date: 15 th December 2008

Section 5-510(k) Summary. This document is provided in the following pages. DEC

510(k) Summary (c)

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

IQ Corporation c/o Harold G. Haines, Ph.D. President SEP 1 f 2002 South Florida BioAssociates, Inc SW 127h Street Miami, Florida

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

W~c f-t. MAR 2 1 2fl09SC. 5 10(k) summary TRACTION MASTERS, INC. Traction Masters, Inc. AKA: Spinetronics, LLC 9737 NW 65 PL Parkland, Florida 33076

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

September 17, Keeler Instruments Inc. Mr. Eugene R. Van Arsdale Marketing Manager 459 Parkway Broomall, PA 19008

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

J UN (k) SUMMARY AS REQUIRED BY SECTION (C) Mrs. Mitsuko Yoneyama President. Submitted by:

Dental Morelli Ltda.

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

September 25, Dear Ms. McCoy:

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

October 29, Dear Ms. Hartnett:

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

510(K) Summary K102148

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

Summary of Safety and Effectiveness

510(k) Summary SUBMITTER'S NAME, ADDRESS, TELEPHONE NUMBER, CONTACT PERSON, AND DATE SUMMARY PREPARED:

510(K) SUMMARY FEB Submitter: Name of the device: * Common Name: Clinical Chemistry Analyzer (with optional ISE Module) Attachment #2

MAY Attachment (k) Summary 21 CER

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

510(k) Summary Special Premarket Notification 510(k) Section 6

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

Histoacryl Flexible Topical Skin Adhesive April15, 2013

510(k) Summary. This summary of 510(k) safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.

Transcription:

IO 20 20O 4 Fresenius Medical Care RAE Fresenius Optiflux F2ONRe, FI 8NRe and FI 6NR e Single Use Hemodkalyzers "Special" 510(k) Premarket Notification Summary of Safety and Effectiveness This 510O(k) Summary of Safety and Effectiveness is being submitted in accordance with the requirements of SMDA 1990. A. Submitter's Information: Name: Address: Fresenius Medical Care North America 95 Hayden Ave Two Ledgemont Center Lexington, MA 02420 Phone: 1-781-402-9068 Fax: (781) 402-9635 Contact Person: Date of Preparation: 19 November, 2004 B. Device Name: Arthur Eilinsfeld, Director of Regulatory Affairs Proprietary Name: Fresenius Optiflux F2ONRe, F18NR 0 and F16NRe Hemodialyzers Common Name: * Optiflux F2oNReandOptifiux F18NRC: Dialyzer, High Permeability with or without Sealed Dialysate System * Optiflux F16NRe: Dialyzer, Capillary, Hollow Fiber Product Code/Classification Panel: * Optiflux F2ONRe andaptiflux Fl8NR 0 : 78KDI/Gastroenterology-Urology * Optiflux F16NR 0 : 78FJI/Gastroenterology-Urology Classification: * Optiflux F20NR'andOptiflux F18NRe: Class II per 876.5860 * Optiflux F16NR 0 : Class II per 876.5820 000042

5AOE 2 cf-- Fresenius Medical Care Fresenius Optiflux F20NRe, F18NRe and F16NRe Single Use Hemodialyzers "Special" 510(k) Premarket Notification Summary of Safety and Effectiveness C. Predicate Devices The Fresenius Optiflux F20NR 0, F18NR 0, and F16NRe are modified versions of the Fresenius Optiflux 200NR and Fresenius Hemoflow F7NR 0, which were cleared under the following premarket notifications: Optiflux 200NR: * K002277 (8/25/00) Hemoflow F7NR 0 * #K002761 (12/04/00) D. Indications for Use/Intended Use Optiflux F20NRt, F18NRt, and F16NR 0 dialyzers are designed for single use acute and chronic hemodialysis. E. Substantial Equivalence: 1. Is the product a device? YES - The Fresenius Optiflux F20NR e, F18NRe, and F16NRe hemodialyzers are devices pursuant to 21 CFR 201 [321] (h). 2. Does the new device have the same intended use? YES - The intended use for the Optiflux F20NR e, F18NR 0, and F16NRe hemodialyzers is equivalent to that for the Fresenius Optiflux 200NR and is as follows: Optiflux F2ONRe. F18NRe, and F16NRe - Intended Use Optiflux F20NRF, F18NR, and F16NRt dialyzers are designed for single use acute and chronic hemodialysis. Fresenius Optiflux 200NR - Intended Use Optiflux 200NR dialyzers are designed for acute and chronic hemodialysis and are appropriate for single and multiple use. 000043

PA c2-4 4 V Fresenius Medical Care Fresenius Optiflux F20NR% F18NRe and F16NRe Single Use Hemodialyzers "Special" 510(k) Premarket Notification Summary of Safety and Effectiveness 3. Does the device have technological characteristics that raise new types of safety or effectiveness questions? NO - The Optifiux F20NRe, F18NRe, and F16NRe are e-beam sterilized, low-flux versions of the Optifiux 200NR. The technological characteristics of the Optiflux F20NR, F18NR 0, and F16NR e are equivalent to those of the Optiflux 200NR and Hemoflow F7NRe and raise no new types of safety or effectiveness questions. 4. Does descriptive or performance information demonstrate equivalence? YES - Fresenius Medical Care North America believes that the information provided in this submission clearly describes the Optiflux F20NR 0, F18NR e, and F16NR' and demonstrates that they are substantially equivalent to the Fresenius Optiflux 200NR and Hemoflow F7NR 0. F. Safety Summary The Optiflux F20NR 0, F18NR e, and F16NR' dialyzers are substantially equivalent in construction, design, materials, and intended use to the commercially available Fresenius F7NRe and Fresenius Optiflux 200NR dialyzers. In addition, testing of the Optiflux F20NR e, F18NRC, and F16NR 0 indicates that they are safe and effective for their intended use. 0000.2&

'7 ~~~DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard DEC 20042 0 ~~~~Rockville MD 20850 Ms. Nichole Riek Regulatory Affairs Supervisor Fresenius Medical Care North America 95 Hayden Avenue LEXINGTON MA 02420 Re: K043244 Trade/Device Name: Fresenius Optiflux 2ONRe, I8NRe and I6NRe Hemodialyzers Regulation Number: 21 CFR 876.5860 Regulation Name: High permeability hemodialysis system Product Code: 78 KDI Regulation Number: 21 CFR 876.5820 Regulation Name: Hemodialysis system and accessories Product Code: 78 FJI Regulatory Class: 11 Dated: November 19, 2004 Received: November 2S, 2004 Dear Ms. Riek: We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class LI (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal eise. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 802); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter: 21 CFR 876.xxxx (Gastroenterology/Renal/Urology) 240-276-0115 21 CFR 884.xxxx (Obstetrics/Gynecology) 240-276-0115 21 CFR 892.xxxx (Radiology) 240-276-0120 Other 240-276-0100 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.iov/cdrh/dsma/dsmamain.html Sincerely yours, Enclosure Nan4cyC.rogdoon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Indications for Use 510(k) Number (if known): Device Name: K043244 Fresenius Optiflux F20NR e, F18NRe, and F16NR e Hremodialyzers Indications For Use: Optiflux F20NRe, F1 8NR e, and F1 6NRe dialyzers are designed for single use acute and chronic hemodialysis. Prescription Use [/ -AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-0ff) Division of Reproductive, Divisi Abdominal,Pae1o ~~~~~~~Page 1 of1 1 and Radiological Devices.2 510(k) Number.